Fig. 3From: Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissueImmunohistochemical expression of E-cadherin in papillary thyroid carcinoma (PTC) a High membranous expression in non-neoplastic thyroid follicles × 100, b High membranous expression in non-neoplastic thyroid follicles x400, c low membranous expression in poorly differentiated PTC stage IVx400Back to article page